News
News

The latest updates from AFAR.

Grantee in the News: Beeson Scholar & Chair Thomas M. Gill on hospice admission in JAGS and Futurity

Sep 18
2017

Grantee in the News: Beeson Scholar & Chair Thomas M. Gill on hospice admission in JAGS and Futurity View MoreBACK

 

On September 12, 2017, the Journal of the American Geriatrics Society published research co-authored by 1997 Beeson Scholar and current Beeson Program Advisory Committee Chair Thomas M. Gill, MD evaluating the relationship between the presence and number of restricting symptoms and number of disabilities and subsequent admission to hospice at the end of life.

In “Distressing Symptoms, Disability, and Hospice Services at the End of Life: Prospective Cohort Study,” Gill and his co-authors found that hospice services appear to be suitably targeted to older persons with the greatest needs at the end of life, although the short duration of hospice suggests that additional strategies are needed to better address the high burden of distressing symptoms and disability at the end of life.

The research was also published on Futurity.org, where Gill notes: “Failing or delaying to refer older persons to hospice at the end of life can place a high burden on caregivers and result in patient suffering.”

The original research in the Journal of the American Geriatrics Society can be found here.

The related Futurity story can be read here.

Thomas Michael Gill, MD, is the Humana Foundation Professor of Medicine (Geriatrics) and Professor of Epidemiology (Chronic Diseases) and of Investigative Medicine at Yale University, where his is also Director, Yale Program on Aging; Director, Claude D. Pepper Older Americans Independence Center; Director, Yale Center for Disability and Disabling Disorders; and Director, Yale Training Program in Geriatric Clinical Epidemiology and Aging-Related Research.


For more on age-related diseases that affect caregiving and hospice admission, visit AFAR’s expert-edited Infoaging Disease Center.
 





View MoreBACK TO TOP